+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Nerve Repair & Regeneration Market (2021-2026) by Product, Application, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon


  • 175 Pages
  • December 2021
  • Region: Global
  • Infogence Global Research
  • ID: 5544199
The Global Nerve Repair & Regeneration Market is estimated to be USD 9.1 Bn in 2021 and is expected to reach USD 17.59 Bn by 2026, growing at a CAGR of 14.09%.

Market Dynamics

Rising cases of neurological disorders are the key factors driving the market. The senior population is at higher risk of neurological conditions such as strokes, neuropathy, etc. Their higher susceptibility makes geriatric a key segment for the patient pool. As a result, the growth of this population segment will ensure continued growth and demand. Emerging countries such as India, China, and Brazil anticipate offering potential growth opportunities for the nerve repair & regeneration market. Reason, huge population base in China and India. Improved treatment for neurological disorders due to several technological advancements is also likely to contribute to market growth. Numerous treatment therapies are available for health problems expected to boost the change in the market. However, stringent restrictive necessities for product approvals act as a restraining issue for market growth. On the contrary, lack of awareness among patients and physicians about nerve repair and regeneration products and techniques and shortage of skilled professionals are crucial factors limiting the market growth.

Market Segmentation

  • The Global Nerve Repair & Regeneration Market is segmented further based on Product, Application, and Geography.
  • By Product Type, the market is classified as Neurostimulation and Neuromodulation devices and Vagus nerve stimulation.
  • By Application, the market is classified as Neurostimulation and Neuromodulation applications, Direct Nerve Repair/ Neurorrhaphy, Nerve Grafting, Stem cell therapy.
  • By Geography, America is projected to lead the market.

Recent Developments

Orthocell limited received an Australian patent for its Celgro collagen medical device platform, covering the suture-less repair of soft tissue defects. - January 2018
AxoGen, Inc. expands its platform for nerve repair to address breast reconstruction neurotization following mastectomy. - November 2017

Company Profiles

Some of the companies covered in this report are Medtronic Plc., Boston scientific corporation, Abbott Laboratories, AxoGen Inc., Baxter International Inc., LivaNova Plc., Integra Lifesciences, Polyganics, NeuroPace Inc., Soterix Medical Inc., Nevro Corp, Synapse Biomedical Inc., Aleva Neurotherapeutics, Collagen Matric Inc., KeriMedical, BioWave Corporation, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Nerve Repair & Regeneration Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includesin-depth market analysis using Porter’s 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.
  • The report also contains the competitive analysis using a Competitive Quadrant, the analyst's proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Nerve Repair & Regeneration Market

What is the estimated value of the Global Nerve Repair & Regeneration Market?

The Global Nerve Repair & Regeneration Market was estimated to be valued at $9.1 Billion in 2021.

What is the growth rate of the Global Nerve Repair & Regeneration Market?

The growth rate of the Global Nerve Repair & Regeneration Market is 14.1%, with an estimated value of $17.59 Billion by 2026.

What is the forecasted size of the Global Nerve Repair & Regeneration Market?

The Global Nerve Repair & Regeneration Market is estimated to be worth $17.59 Billion by 2026.

Who are the key companies in the Global Nerve Repair & Regeneration Market?

Key companies in the Global Nerve Repair & Regeneration Market include Medtronic Plc., Boston scientific corporation, Abbott Laboratories, AxoGen Inc., Baxter International Inc., LivaNova Plc., Integra Lifesciences, Polyganics and Soterix Medical Inc..

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook
4 Market Influencers
4.1 Drivers
4.1.1 Rising Geriatric Population and Subsequent Growth in the Prevalence of Neurological Disorders
4.1.2 Rising Case of Neurological Disorder
4.2 Restraints
4.2.1 Stringent Regulatory Requirements for Product Approval
4.3 Opportunities
4.3.1 Positive Indicator for Market Growth
4.3.2 Improved Treatment for Neurological Disorder
4.3.3 Availability of Therapies for Treatment of Various Issues
4.4 Challenges
4.4.1 Lack of Awareness among People
5 Market Analysis
5.1 Porter’s Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis
6 Global Nerve Repair & Regeneration Market, By Product Type
6.1 Introduction
6.2 Neurostimulation and Neuromodulation devices
6.2.1 Internal Neurostimulation Devices Spinal Cord Stimulation Deep Brain Stimulation Vagus Nerve Stimulation Sacral Nerve Stimulation Gastric Electrical Stimulation
6.2.2 External Neurostimulation Devices TENS TMS RES
6.2.3 Biomaterials Nerve Conduits Nerve wraps Nerve protectors Nerve connectors
6.3 Vagus Nerve Simulation
7 Global Nerve Repair & Regeneration Market, By Application
7.1 Introduction
7.2 Neurostimulation and Neuromodulation Applications
7.2.1 Internal Neurostimulation and Neuromodulation Applications
7.2.2 External Neurostimulation and Neuromodulation Devices
7.3 Direct Nerve Repair/ Neurorrhaphy
7.3.1 Epineural Repair
7.3.2 Perineural Repair
7.3.3 Group Fascicular Repair
7.4 Nerve Gifting
7.4.1 Autografts
7.4.2 Allografts
7.4.3 Xenografts
7.5 Stem Cell Therapy
8 Global Nerve Repair & Regeneration Market, By Geography
8.1 Introduction
8.2 America
8.2.1 Argentina
8.2.2 Brazil
8.2.3 Canada
8.2.4 Chile
8.2.5 Colombia
8.2.6 Mexico
8.2.7 Peru
8.2.8 United States
8.2.9 Rest of Americas
8.3 Europe
8.3.1 Austria
8.3.2 Belgium
8.3.3 Denmark
8.3.4 Finland
8.3.5 France
8.3.6 Germany
8.3.7 Italy
8.3.8 Netherlands
8.3.9 Norway
8.3.10 Poland
8.3.11 Russia
8.3.12 Spain
8.3.13 Sweden
8.3.14 Switzerland
8.3.15 United Kingdom
8.3.16 Rest of Europe
8.4 Middle East and Africa
8.4.1 Egypt
8.4.2 Israel
8.4.3 Qatar
8.4.4 Saudi Arabia
8.4.5 South Africa
8.4.6 United Arab Emirates
8.4.7 Rest of MEA
8.5 Asia-Pacific
8.5.1 Australia
8.5.2 Bangladesh
8.5.3 China
8.5.4 India
8.5.5 Indonesia
8.5.6 Japan
8.5.7 Malaysia
8.5.8 Philippines
8.5.9 Singapore
8.5.10 South Korea
8.5.11 Sri Lanka
8.5.12 Thailand
8.5.13 Taiwan
8.5.14 Rest of Asia
9 Competitive Landscape
9.1 Competitive Quadrant
9.2 Market Share Analysis
9.3 Strategic Initiatives
9.3.1 M&A and Investments
9.3.2 Partnerships and Collaborations
9.3.3 Product Developments and Improvements
10 Company Profiles
10.1 Medtronic Plc.
10.2 Boston scientific corporation
10.3 Abbott Laboratories
10.4 AxoGen Inc.
10.5 Baxter International Inc.
10.6 LivaNova Plc.
10.7 Integra Lifesciences
10.8 Polyganics
10.9 NeuroPace Inc.
10.10 Soterix Medical Inc.
10.11 Nevro Corp
10.12 Synapse Biomedical Inc.
10.13 Aleva Neurotherapeutics
10.14 Collagen Matric Inc.
10.15 KeriMedical
10.16 BioWave Corporation
10.17 NeuroSigma
10.18 tVNS Technologies GmbH
10.19 GiMer Medical
10.24 St. Jude medical Inc.
10.25 NeuroSigma
11 Appendix
11.1 Questionnaire

Companies Mentioned

  • Medtronic Plc.
  • Boston scientific corporation
  • Abbott Laboratories
  • AxoGen Inc.
  • Baxter International Inc.
  • LivaNova Plc.
  • Integra Lifesciences
  • Polyganics
  • NeuroPace Inc.
  • Soterix Medical Inc.
  • Nevro Corp
  • Synapse Biomedical Inc.
  • Aleva Neurotherapeutics
  • Collagen Matric Inc.
  • KeriMedical
  • BioWave Corporation
  • NeuroSigma
  • tVNS Technologies GmbH
  • GiMer Medical
  • St. Jude medical Inc.
  • NeuroSigma